Exagen Inc. (XGN) Operating cash flow 2018–2025
Exagen Inc. (XGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$13.6MFY2025 · since FY2018: -$9.3M → -$13.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.6M | -2.6% |
| FY2024 | -$13.3M | +8.2% |
| FY2023 | -$14.5M | +55.0% |
| FY2022 | -$32.1M | -58.6% |
| FY2021 | -$20.3M | -43.9% |
| FY2020 | -$14.1M | -45.0% |
| FY2019 | -$9.7M | -4.4% |
| FY2018 | -$9.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice